Thermo Fisher Scientific (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,583,000 | 10,325,000 | 7,540,000 | 5,818,000 | 2,981,000 |
| Receivables | 5,554,000 | 5,741,000 | 5,186,000 | 4,478,000 | 4,508,000 |
| Inventories | 4,342,000 | 4,029,000 | 3,829,000 | 3,648,000 | 3,454,000 |
| Other current assets | 2,206,000 | 1,862,000 | 1,679,000 | 1,831,000 | 1,795,000 |
| TOTAL | $17,685,000 | $21,957,000 | $18,234,000 | $15,775,000 | $12,738,000 |
| Non-Current Assets | |||||
| PPE Net | 6,133,000 | 5,912,000 | 5,180,000 | 4,887,000 | 4,736,000 |
| Intangibles | 39,654,000 | 38,726,000 | 38,652,000 | 38,870,000 | 39,157,000 |
| Other Non-Current Assets | 2,459,000 | 2,457,000 | 1,995,000 | 2,061,000 | 2,057,000 |
| TOTAL | $48,246,000 | $47,095,000 | $45,827,000 | $45,818,000 | $45,950,000 |
| Total Assets | $65,931,000 | $69,052,000 | $64,061,000 | $61,593,000 | $58,688,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,146,000 | 2,175,000 | 1,703,000 | 1,385,000 | 1,599,000 |
| Accrued Expenses | 1,314,000 | 1,916,000 | 1,538,000 | 1,184,000 | 755,000 |
| Other current liabilities | 1,396,000 | 1,271,000 | 1,047,000 | 975,000 | 938,000 |
| TOTAL | $6,995,000 | $10,304,000 | $6,228,000 | $6,013,000 | $5,500,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 18,641,000 | 19,107,000 | 21,091,000 | 20,638,000 | 19,231,000 |
| Other Non-Current Liabilities | 3,352,000 | 3,330,000 | 3,390,000 | 3,317,000 | 3,261,000 |
| TOTAL | $23,878,000 | $24,231,000 | $26,009,000 | $25,705,000 | $24,629,000 |
| Total Liabilities | $30,873,000 | $34,535,000 | $32,237,000 | $31,718,000 | $30,129,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 393,028 | 393,793 | 396,335 | 395,589 | 394,951 |
| Common Shares | 438,000 | 437,000 | 437,000 | 436,000 | 435,000 |
| Retained earnings | 30,350,000 | 28,116,000 | 25,705,000 | 23,860,000 | 22,791,000 |
| Other shareholders' equity | -2,562,000 | -2,797,000 | -2,970,000 | -2,989,000 | -3,088,000 |
| TOTAL | $35,058,000 | $34,517,000 | $31,824,000 | $29,875,000 | $28,559,000 |
| Total Liabilities And Equity | $65,931,000 | $69,052,000 | $64,061,000 | $61,593,000 | $58,688,000 |